Laboratory Corporation of America Holdings company logo

# 1st Gen Model Laboratory Corporation of America Holdings Medical laboratories

82.26% successful of 62 deals
$156.55 Last close price
at 21-jul-2017

LH

Model's trade recommendations 0.15% Return for period

18.12% Annual return

$15.86B Market Cap

β 0.93  

LH

Model (following trade recommendations)

LH

Underlying stock

S&P 500

Index
Return for period 0.15%
3.25%
1.78%
52wk return 16.40%
12.77%
16.82%
52wk Range
121.63—156.55
2000.54—2399.63
Sortino ratio 4.37
Sharpe ratio 2.44
Norm. RMSE 0.53%
Downside risk 3.79%
Volatility 6.79%
  • STRONG BUY Analysts consensus recommendation

Laboratory Corporation of America Holdings, is one of the largest independent clinical laboratory company's in the United States. Through a national network of laboratories, the company offers different clinical laboratory tests which are used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease.

Industry sector: Medical

Sector classification: Medical laboratories

Deep Learning based analysis and prediction model for Laboratory Corporation of America Holdings (LH) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 22, 2015.

Market data for LH model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 101M
P/E 17.36
Shares Outstanding 102M
% Held by Insiders 0.90%
% Held by Institutions 91.09%
EPS (last reported FY) $8.83
EPS (last reported Q) $2.22
EPS, estimated (last reported Q) $2.19
Total revenues $10 B
Net income $1 B